Xianju Pharmaceutical: Net profit of 450 million yuan in 2025, a year-on-year increase of 13.21%

Xianju Pharmaceutical Announcement, 2025 operating revenue of 3.76B yuan, down 6.04% year-on-year. Net profit of 450 million yuan, up 13.21% year-on-year. The profit distribution plan approved by the company’s board of directors is: based on 989 million shares, distribute a cash dividend of 2 yuan (tax included) for every 10 shares to all shareholders, with 0 bonus shares (tax included), and no capital increase through reserve funds.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin